The sensitivity of CLL cells to in vitro spontaneous apoptosis and autocrine IL-6 production reflects the status of constitutive activities of STAT3/NF-κB, chemo-responsiveness and clinical outcome of patients with CLL. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.